If you want the shortest honest answer: manufacturer savings can help in 2026, but only if you are using the right program for your situation. For eligible commercially insured patients, the current official pages for Wegovy, Ozempic, Mounjaro, and Zepbound all advertise meaningful savings, often with a $25 headline on the insured side. But those are not universal coupons. They usually exclude government beneficiaries, follow strict terms, and do not stack with other discount programs. [1] [2] [3] [5]
The second thing readers miss is that a savings card is not the same as patient assistance. A savings card lowers what an eligible patient pays at the pharmacy. A patient assistance program is a separate no-cost route with income and insurance gates, and it usually takes more paperwork. [6] [9]
If you want the broader access picture first, read our insurance guide, cheapest-way guide, Medicare coverage guide, and Ozempic vs. Mounjaro comparison.
The Fastest Way to Match Yourself to the Right Program
Use this before you click any coupon page:
| Your situation | Best first step | Why |
|---|---|---|
| You have commercial insurance and the drug is covered | Try the official manufacturer savings page first. [1] [2] [3] [5] | This is the group those $25 headline offers are built for. |
| You have commercial insurance, but coverage is unclear | Check coverage first, then the savings page. [1] [5] | The card helps most when the plan already recognizes the drug. |
| You are self-pay and want brand medication | Check the official self-pay pricing, not random coupon sites. [1] [2] [3] | Self-pay offers exist, but they are dose-specific and can change. |
| You have Medicare, Medicaid, VA, or TRICARE | Do not assume the savings card applies. Read the exclusions and look at coverage or program-specific help instead. [1] [2] [5] | Government beneficiaries are usually excluded from these card offers. |
| You are uninsured and low income | Check patient assistance separately. [6] [9] | That is the real no-cost lane, and it is not the same as a coupon. |
What the Current Manufacturer Offers Actually Say
Wegovy
Wegovy’s current official page is unusually clear about splitting the offer into two lanes. For eligible commercially insured patients, the page says they can pay as little as $25 per month. On the self-pay side, new patients using the lower starter pen doses can pay $199 per month for the 0.25 mg and 0.5 mg doses for two monthly fills through June 30, 2026, then the pricing moves to $349 per month for most Wegovy pen doses and $399 per month for Wegovy HD 7.2 mg. [1]
That is useful, but it is not a universal coupon. The same page says the insured offer is subject to eligibility restrictions, the self-pay pricing varies by dose, and the terms can change. [1]
Ozempic
Ozempic’s current savings page follows the same basic pattern, but with diabetes-specific dosing and pricing. For commercially insured patients with coverage, the page says they can pay as little as $25. For self-pay patients, the page currently lists $199 per month for the first two months of 0.25 mg or 0.5 mg for new patients, then $349 per month for 0.25 mg, 0.5 mg, or 1 mg, and $499 per month for 2 mg. [2]
That distinction matters because a lot of readers see the intro number and assume that is the long-term cash price. It is not. The official page makes clear that the lower self-pay amount is a limited-time intro pathway rather than the ongoing price for every dose and every patient. [2]
Zepbound
If you are looking at weight-loss tirzepatide rather than diabetes tirzepatide, the relevant official savings page is Zepbound, not Mounjaro. Lilly’s current Zepbound page is one of the clearest self-pay brand pages in this category. The offer language currently shows $299 for 2.5 mg, $399 for 5 mg, and $449 for 7.5 mg through 15 mg under the current offer terms. [3]
That clarity is useful, but you still have to read the restrictions. The page says the offer is tied to eligibility rules, that some terms depend on whether commercial coverage exists, and that the savings cannot be combined with other discount programs. The page also says card savings end on December 31, 2026 under the current terms language. [3]
Mounjaro
Mounjaro is the tirzepatide brand used on the diabetes side, so its savings page is not interchangeable with Zepbound’s. The current Mounjaro savings workflow says patients may pay as little as $25 for up to a 3-month prescription if eligible, and if the insurance or pharmacy will not process a 3-month fill, the patient may still be able to use the savings card on a 1-month prescription. [4]
The current FAQ adds the most important qualifier: eligible, commercially insured patients with Mounjaro coverage can pay as little as $25 for up to a 3-month prescription, and governmental beneficiaries are excluded. [5]
That is the pattern across this category: manufacturer savings can be excellent, but the official pages are aiming at a narrower group than “anyone who wants a coupon.”
The Part Most Readers Get Wrong: A Savings Card Is Not a PAP
If you are uninsured or your insurance is unusable, you may not need a savings card at all. You may need a patient assistance program, which is a different lane entirely.
Novo Nordisk’s current Patient Assistance Program page says the program provides medicine at no cost to qualifying patients and that there is no registration charge or monthly fee. But the same page also says patients with private or commercial insurance are not eligible. [6]
This is where people get confused. A savings card lowers a fill at the pharmacy. A PAP helps a narrower patient get medication at no cost after income and insurance screening. Those are not interchangeable programs. [6]
The current NovoCare PAP page also makes the rules more specific than many roundup articles do:
- It says applicants must have qualifying household income and either Medicare or no insurance. [6]
- It says Medicare beneficiaries with Part D coverage will no longer be eligible to receive Ozempic through the PAP. [6]
- It says uninsured Ozempic patients can still have access through the PAP, but their household income must be at or below 200% of the federal poverty level. [6]
Using the current HHS 2026 poverty-guideline table for the 48 contiguous states and D.C., that means:
- Household of 1: base guideline $15,960, so 200% FPL = $31,920 and 400% FPL = $63,840. [9]
- Household of 4: base guideline $33,000, so 200% FPL = $66,000 and 400% FPL = $132,000. [9]
Alaska and Hawaii use higher separate guideline tables, so do not use the contiguous-state figures if you live there. [9]
The practical lesson is simple: if you need a true $0 route, stop searching for “coupon” and start checking whether you meet a real PAP screen.
Can You Use These Offers With Insurance, GoodRx, or Medicare?
With commercial insurance
This is the most coupon-friendly group. Wegovy, Ozempic, and Mounjaro all currently frame their best savings language around eligible commercially insured patients, and Mounjaro explicitly ties the $25 language to patients with coverage. [1] [2] [5]
In other words, these programs are often designed to reduce a covered copay, not to replace the insurance benefit entirely.
With Medicare, Medicaid, or other government coverage
The current Wegovy and Ozempic savings pages exclude government beneficiaries, and the Mounjaro FAQ uses the same exclusion language. [1] [2] [5]
So if you have Medicare, Medicaid, VA, or TRICARE, do not start by assuming the manufacturer savings card will apply. Your better first question is whether you have a program-specific coverage route, bridge model, or support option instead.
With GoodRx or another discount card
Do not assume coupon stacking works. NovoCare’s current pharmacy terms say the offer cannot be combined with any other coupon, free trial, discount, prescription savings card, or similar offer. Lilly’s current Zepbound savings language says the card savings cannot be combined with other discount programs either. [3] [7]
That means the real-world rule is:
Compare the manufacturer offer against the other discount option. Do not expect both to apply to the same fill.
Will the cheaper fill help my deductible?
Not always. Ozempic’s current official terms say that self-pay offers processed outside insurance will not count toward deductibles and cannot be applied to insurance maximum out-of-pocket limits. [8]
That matters more than most coupon articles admit. A lower price today may not help your annual benefit math if it bypasses insurance.
Step-by-Step: How to Use a Manufacturer Savings Offer Without Wasting a Refill
- Confirm the exact drug and brand. Wegovy and Ozempic are semaglutide brands, but they are not the same program. Zepbound and Mounjaro are tirzepatide brands, but they are not the same program either. [1] [2] [3] [5]
- Check whether you are in the right insurance bucket. Commercial insurance is the main target for the best savings-card offers. Government coverage usually is not. [1] [2] [5]
- Read the official terms, not just the banner price. The banner tells you the best-case number. The terms tell you whether you qualify, whether the offer expires, and whether it helps your deductible. [3] [7] [8]
- Use the manufacturer’s support line if the pharmacy rejects it. Wegovy lists a dedicated savings-offer support number and pharmacy help desk, while Mounjaro directs patients to Lilly Support Services. [1] [4]
- If you are uninsured and low income, pivot to PAP early. Do not spend days trying to force a retail coupon into a no-insurance problem. [6] [9]
The Most Honest Decision Checklist
Use this if you just want the next right move:
- Wegovy with commercial coverage: Start with the official Wegovy savings page. [1]
- Ozempic with commercial coverage: Start with the official Ozempic savings page, but do not assume the intro self-pay offer is your long-term price. [2]
- Weight-loss tirzepatide: Use the Zepbound savings page, not the Mounjaro one. [3]
- Diabetes tirzepatide: Use the Mounjaro savings page and verify that your plan actually covers the drug. [4] [5]
- No insurance and low income: Check patient assistance, not coupon blogs. [6] [9]
- Medicare or Medicaid: Assume the standard savings card may not apply until the official page proves otherwise. [1] [2] [5]
- Planning to stack GoodRx with a manufacturer offer: Expect that to fail unless the current terms explicitly allow it. [3] [7]
Bottom Line
The best way to think about GLP-1 manufacturer coupons in 2026 is this:
- Savings cards are real and useful, but mostly for eligible commercially insured readers.
- Self-pay offers can still help, but they are often dose-based, time-limited, and not the same thing as broad cash pricing.
- Patient assistance is the true no-cost lane, but it is a separate program with tighter rules.
The right question is not “Is there a coupon?” It is:
Which lane am I actually in: covered commercial insurance, self-pay brand pricing, or real patient assistance?
Once you answer that, the official manufacturer pages start making a lot more sense.
